rxstat › Shortages › Octreotide
Octreotide shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Octreotide products are in shortage in Canada (1 of 14 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
In shortage since
Jun 17, 2024
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageSANDOSTATIN
50MCG · SOLUTION · NOVARTIS PHARMACEUTICALS CANADA INC
DIN 00839191 · since Jun 17, 2024, no end estimate · Disruption of the manufacture of the drug.
ResolvedOCTREOTIDE ACETATE OMEGA
100MCG · SOLUTION · OMEGA LABORATORIES LIMITED
DIN 02248640 · ended May 28, 2026 · Disruption of the manufacture of the drug.
ResolvedOCTREOTIDE ACETATE OMEGA
500MCG · SOLUTION · OMEGA LABORATORIES LIMITED
DIN 02248641 · ended May 12, 2026 · Disruption of the manufacture of the drug.
ResolvedSANDOSTATIN
100MCG · SOLUTION · NOVARTIS PHARMACEUTICALS CANADA INC
DIN 00839205 · ended Jan 31, 2025 · Disruption of the manufacture of the drug.
DiscontinuedOCTREOTIDE FOR INJECTABLE SUSPENSION
30MG · POWDER FOR SUSPENSION, SUSTAINED-RELEASE
KIT · TEVA CANADA LIMITED
DIN 02503786
DiscontinuedOCTREOTIDE FOR INJECTABLE SUSPENSION
20MG · POWDER FOR SUSPENSION, SUSTAINED-RELEASE
KIT · TEVA CANADA LIMITED
DIN 02503778
DiscontinuedOCTREOTIDE FOR INJECTABLE SUSPENSION
10MG · POWDER FOR SUSPENSION, SUSTAINED-RELEASE
KIT · TEVA CANADA LIMITED
DIN 02503751
ResolvedOCTREOTIDE FOR INJECTABLE SUSPENSION
30MG · POWDER FOR SUSPENSION, SUSTAINED-RELEASE
KIT · TEVA CANADA LIMITED
DIN 02503786 · ended May 5, 2026 · Disruption of the manufacture of the drug.
ResolvedOCTREOTIDE FOR INJECTABLE SUSPENSION
20MG · POWDER FOR SUSPENSION, SUSTAINED-RELEASE
KIT · TEVA CANADA LIMITED
DIN 02503778 · ended May 5, 2026 · Disruption of the manufacture of the drug.
ResolvedOCTREOTIDE FOR INJECTABLE SUSPENSION
10MG · POWDER FOR SUSPENSION, SUSTAINED-RELEASE
KIT · TEVA CANADA LIMITED
DIN 02503751 · ended May 5, 2026 · Disruption of the manufacture of the drug.
ResolvedSANDOSTATIN LAR
30MG · POWDER FOR SUSPENSION, SUSTAINED-RELEASE · NOVARTIS PHARMACEUTICALS CANADA INC
DIN 02239325 · ended Mar 4, 2026 · Demand increase for the drug.
ResolvedOCTREOTIDE ACETATE OMEGA
500MCG · SOLUTION · OMEGA LABORATORIES LIMITED
DIN 02248641 · ended Feb 18, 2026 · Disruption of the manufacture of the drug.
Showing 12 of 44 reports. All reports are on file with Health Canada.
What's happening
Octreotide is currently affected by an active shortage report filed with Health Canada by NOVARTIS PHARMACEUTICALS CANADA INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Octreotide is classified under “HYPOTHALAMIC HORMONES” (ATC H01CB).
Recent changes
Common questions
When will Octreotide be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Octreotide in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.